Intranasal Neuropeptide Administration To Target the Human Brain in Health and Disease

Molecular Pharmaceutics

Volumn 12, Issue 8, 2015, Pages 2767-2780

  Spetter, Maartje S ^a   Hallschmid, Manfred ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

brain; central nervous system; cognitive function; glucose homeostasis; insulin; intranasal administration; leptin; memory; metabolism; oxytocin

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; LEPTIN; NEUROPEPTIDE; OXYTOCIN; ANTIDIABETIC AGENT;

ADRENERGIC SYSTEM; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; BROWN ADIPOSE TISSUE; CALORIC INTAKE; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DIET INDUCED OBESITY; DRUG TARGETING; ENERGY EXPENDITURE; FOOD INTAKE; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; LIPOGENESIS; LIPOLYSIS; MEMORY DISORDER; METABOLIC DISORDER; METABOLIC REGULATION; MILD COGNITIVE IMPAIRMENT; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PILOT STUDY; PRIORITY JOURNAL; REWARD; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; THERMOGENESIS; WHITE ADIPOSE TISSUE; ANIMAL; BRAIN; BRAIN DISEASES; DRUG DELIVERY SYSTEM; DRUG EFFECTS; HEALTH; INTRANASAL DRUG ADMINISTRATION; METABOLIC DISEASES; METABOLISM; PHYSIOLOGY; PROCEDURES;

ADMINISTRATION, INTRANASAL; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN DISEASES; DRUG DELIVERY SYSTEMS; HEALTH; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; METABOLIC DISEASES; NEUROPEPTIDES;

EID: 84938304156     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.5b00047     Document Type: Article

References (195)

1. Begg, D. P.; Woods, S. C. The endocrinology of food intake Nat. Rev. Endocrinol. 2013, 9, 584-597
2. Woods, S. C.; Seeley, R. J.; Baskin, D. G.; Schwartz, M. W. Insulin and the blood-brain barrier Curr. Pharm. Des. 2003, 9, 795-800
3. Schwartz, M. W.; Peskind, E.; Raskind, M.; Boyko, E. J.; Porte, D., Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans Nat. Med. 1996, 2, 589-593
4. Woods, S. C.; Lotter, E. C.; McKay, L. D.; Porte, D., Jr. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons Nature 1979, 282, 503-505
5. Air, E. L.; Benoit, S. C.; Clegg, D. J.; Seeley, R. J.; Woods, S. C. Insulin and leptin combine additively to reduce food intake and body weight in rats Endocrinology 2002, 143, 2449-2452
6. Bruning, J. C.; Gautam, D.; Burks, D. J.; Gillette, J.; Schubert, M.; Orban, P. C.; Klein, R.; Krone, W.; Muller-Wieland, D.; Kahn, C. R. Role of brain insulin receptor in control of body weight and reproduction Science 2000, 289, 2122-2125
7. Friedman, J. M.; Mantzoros, C. S. 20 years of leptin: From the discovery of the leptin gene to leptin in our therapeutic armamentarium Metabolism 2015, 64, 1-4
8. Devaskar, S. U.; Giddings, S. J.; Rajakumar, P. A.; Carnaghi, L. R.; Menon, R. K.; Zahm, D. S. Insulin gene expression and insulin synthesis in mammalian neuronal cells J. Biol. Chem. 1994, 269, 8445-8454
9. Pocai, A.; Lam, T. K.; Gutierrez-Juarez, R.; Obici, S.; Schwartz, G. J.; Bryan, J.; guilar-Bryan, L.; Rossetti, L. Hypothalamic K(ATP) channels control hepatic glucose production Nature 2005, 434, 1026-1031
10. Rulifson, E. J.; Kim, S. K.; Nusse, R. Ablation of insulin-producing neurons in flies: growth and diabetic phenotypes Science 2002, 296, 1118-1120
11. Davis, J. F.; Choi, D. L.; Benoit, S. C. Insulin, leptin and reward Trends Endocrinol. Metab. 2010, 21, 68-74
12. Chiu, S. L.; Cline, H. T. Insulin receptor signaling in the development of neuronal structure and function Neural Dev. 2010, 5, 7
13. Hrytsenko, O.; Wright, J. R., Jr.; Morrison, C. M.; Pohajdak, B. Insulin expression in the brain and pituitary cells of tilapia (Oreochromis niloticus) Brain Res. 2007, 1135, 31-40
14. Molnar, G.; Farago, N.; Kocsis, A. K.; Rozsa, M.; Lovas, S.; Boldog, E.; Baldi, R.; Csajbok, E.; Gardi, J.; Puskas, L. G.; Tamas, G. GABAergic neurogliaform cells represent local sources of insulin in the cerebral cortex J. Neurosci. 2014, 34, 1133-1137
15. Liu, L.; Karkanias, G. B.; Morales, J. C.; Hawkins, M.; Barzilai, N.; Wang, J.; Rossetti, L. Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes J. Biol. Chem. 1998, 273, 31160-31167
16. Buettner, C.; Muse, E. D.; Cheng, A.; Chen, L.; Scherer, T.; Pocai, A.; Su, K.; Cheng, B.; Li, X.; Harvey-White, J.; Schwartz, G. J.; Kunos, G.; Rossetti, L.; Buettner, C. Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms Nat. Med. 2008, 14, 667-675
17. Simonds, S. E.; Pryor, J. T.; Ravussin, E.; Greenway, F. L.; Dileone, R.; Allen, A. M.; Bassi, J.; Elmquist, J. K.; Keogh, J. M.; Henning, E.; Myers, M. G., Jr.; Licinio, J.; Brown, R. D.; Enriori, P. J.; O'Rahilly, S.; Sternson, S. M.; Grove, K. L.; Spanswick, D. C.; Farooqi, I. S.; Cowley, M. A. Leptin mediates the increase in blood pressure associated with obesity Cell 2014, 159, 1404-1416
18. Gomez-Pinilla, F. Brain foods: the effects of nutrients on brain function Nat. Rev. Neurosci. 2008, 9, 568-578
19. Meyer-Lindenberg, A.; Domes, G.; Kirsch, P.; Heinrichs, M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine Nat. Rev. Neurosci. 2011, 12, 524-538
20. Morton, G. J.; Thatcher, B. S.; Reidelberger, R. D.; Ogimoto, K.; Wolden-Hanson, T.; Baskin, D. G.; Schwartz, M. W.; Blevins, J. E. Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats Am. J. Physiol. 2012, 302, E134-E144
21. Wu, Z.; Xu, Y.; Zhu, Y.; Sutton, A. K.; Zhao, R.; Lowell, B. B.; Olson, D. P.; Tong, Q. An obligate role of oxytocin neurons in diet induced energy expenditure PLoS One 2012, 7, e45167
22. Ott, V.; Finlayson, G.; Lehnert, H.; Heitmann, B.; Heinrichs, M.; Born, J.; Hallschmid, M. Oxytocin reduces reward-driven food intake in humans Diabetes 2013, 62, 3418-3425
23. Zhang, H.; Wu, C.; Chen, Q.; Chen, X.; Xu, Z.; Wu, J.; Cai, D. Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models PLoS One 2013, 8, e61477
24. Muzumdar, R.; Ma, X.; Yang, X.; Atzmon, G.; Bernstein, J.; Karkanias, G.; Barzilai, N. Physiologic effect of leptin on insulin secretion is mediated mainly through central mechanisms FASEB J. 2003, 17, 1130-1132
25. Chen, M.; Woods, S. C.; Porte, D., Jr. Effect of cerebral intraventricular insulin on pancreatic insulin secretion in the dog Diabetes 1975, 24, 910-914
26. Thorne, R. G.; Emory, C. R.; Ala, T. A.; Frey, W. H. Quantitative analysis of the olfactory pathway for drug delivery to the brain Brain Res. 1995, 692, 278-282
27. Thorne, R. G.; Pronk, G. J.; Padmanabhan, V.; Frey, W. H. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration Neuroscience 2004, 127, 481-496
28. Alcala-Barraza, S. R.; Lee, M. S.; Hanson, L. R.; McDonald, A. A.; Frey, W. H.; McLoon, L. K. Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS J. Drug Targeting 2010, 18, 179-190
29. Dhuria, S. V.; Hanson, L. R.; Frey, W. H. Intranasal delivery to the central nervous system: mechanisms and experimental considerations J. Pharm. Sci. 2010, 99, 1654-1673
30. Born, J.; Lange, T.; Kern, W.; McGregor, G. P.; Bickel, U.; Fehm, H. L. Sniffing neuropeptides: a transnasal approach to the human brain Nat. Neurosci. 2002, 5, 514-516
31. Lacroix, M. C.; Badonnel, K.; Meunier, N.; Tan, F.; Schlegel-Le, P. C.; Durieux, D.; Monnerie, R.; Baly, C.; Congar, P.; Salesse, R.; Caillol, M. Expression of insulin system in the olfactory epithelium: first approaches to its role and regulation J. Neuroendocrinol. 2008, 20, 1176-1190
32. Lochhead, J. J.; Wolak, D. J.; Pizzo, M. E.; Thorne, R. G. Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration J. Cereb. Blood Flow Metab. 2015, 35, 371-381
33. Fliedner, S.; Schulz, C.; Lehnert, H. Brain uptake of intranasally applied radioiodinated leptin in Wistar rats Endocrinology 2006, 147, 2088-2094
34. Illum, L. Transport of drugs from the nasal cavity to the central nervous system Eur. J. Pharm. Sci. 2000, 11, 1-18
35. Costantino, H. R.; Illum, L.; Brandt, G.; Johnson, P. H.; Quay, S. C. Intranasal delivery: physicochemical and therapeutic aspects Int. J. Pharm. 2007, 337, 1-24
36. Krug, R.; Benedict, C.; Born, J.; Hallschmid, M. Comparable sensitivity of postmenopausal and young women to the effects of intranasal insulin on food intake and working memory J. Clin. Endocrinol. Metab. 2010, 95, E468-E472
37. Benedict, C.; Brede, S.; Schioth, H. B.; Lehnert, H.; Schultes, B.; Born, J.; Hallschmid, M. Intranasal insulin enhances postprandial thermogenesis and lowers postprandial serum insulin levels in healthy men Diabetes 2011, 60, 114-118
38. Heni, M.; Kullmann, S.; Ketterer, C.; Guthoff, M.; Linder, K.; Wagner, R.; Stingl, K. T.; Veit, R.; Staiger, H.; Haring, H. U.; Preissl, H.; Fritsche, A. Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions Diabetologia 2012, 55, 1773-1782
39. Dash, S.; Xiao, C.; Morgantini, C.; Koulajian, K.; Lewis, G. F. Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrations Diabetes 2015, 64, 766-774
40. Neumann, I. D.; Maloumby, R.; Beiderbeck, D. I.; Lukas, M.; Landgraf, R. Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice Psychoneuroendocrinology 2013, 38, 1985-1993
41. Ott, V.; Lehnert, H.; Staub, J.; Wonne, K.; Born, J.; Hallschmid, M. Central nervous insulin administration does not potentiate the acute glucoregulatory impact of concurrent mild hyperinsulinemia Diabetes 2015, 64, 760-765
42. Gancheva, S.; Koliaki, C.; Bierwagen, A.; Nowotny, P.; Heni, M.; Fritsche, A.; Haring, H. U.; Szendroedi, J.; Roden, M. Effects of intranasal insulin on hepatic fat accumulation and energy metabolism in humans Diabetes 2015, 10.2337/db14-0892
43. Kern, W.; Born, J.; Schreiber, H.; Fehm, H. L. Central nervous system effects of intranasally administered insulin during euglycemia in men Diabetes 1999, 48, 557-563
44. Hallschmid, M.; Schultes, B.; Marshall, L.; Molle, M.; Kern, W.; Bredthauer, J.; Fehm, H. L.; Born, J. Transcortical direct current potential shift reflects immediate signaling of systemic insulin to the human brain Diabetes 2004, 53, 2202-2208
45. Wallner-Liebmann, S.; Koschutnig, K.; Reishofer, G.; Sorantin, E.; Blaschitz, B.; Kruschitz, R.; Unterrainer, H. F.; Gasser, R.; Freytag, F.; Bauer-Denk, C.; Schienle, A.; Schafer, A.; Mangge, H. Insulin and hippocampus activation in response to images of high-calorie food in normal weight and obese adolescents Obesity 2010, 18, 1552-1557
46. Guthoff, M.; Grichisch, Y.; Canova, C.; Tschritter, O.; Veit, R.; Hallschmid, M.; Haring, H. U.; Preissl, H.; Hennige, A. M.; Fritsche, A. Insulin modulates food-related activity in the central nervous system J. Clin. Endocrinol. Metab. 2010, 95, 748-755
47. Schilling, T. M.; Ferreira de Sa, D. S.; Westerhausen, R.; Strelzyk, F.; Larra, M. F.; Hallschmid, M.; Savaskan, E.; Oitzl, M. S.; Busch, H. P.; Naumann, E.; Schachinger, H. Intranasal insulin increases regional cerebral blood flow in the insular cortex in men independently of cortisol manipulation Hum. Brain Mapp. 2014, 35, 1944-1956
48. Tschritter, O.; Preissl, H.; Hennige, A. M.; Stumvoll, M.; Porubska, K.; Frost, R.; Marx, H.; Klosel, B.; Lutzenberger, W.; Birbaumer, N.; Haring, H. U.; Fritsche, A. The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 12103-12108
49. Tschritter, O.; Preissl, H.; Yokoyama, Y.; Machicao, F.; Haring, H. U.; Fritsche, A. Variation in the FTO gene locus is associated with cerebrocortical insulin resistance in humans Diabetologia 2007, 50, 2602-2603
50. Vogt, M. C.; Bruning, J. C. CNS insulin signaling in the control of energy homeostasis and glucose metabolism-from embryo to old age Trends Endocrinol. Metab. 2013, 24, 76-84
51. Hallschmid, M.; Benedict, C.; Schultes, B.; Fehm, H. L.; Born, J.; Kern, W. Intranasal insulin reduces body fat in men but not in women Diabetes 2004, 53, 3024-3029
52. Benedict, C.; Kern, W.; Schultes, B.; Born, J.; Hallschmid, M. Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin J. Clin. Endocrinol. Metab. 2008, 93, 1339-1344
53. Hallschmid, M.; Higgs, S.; Thienel, M.; Ott, V.; Lehnert, H. Postprandial administration of intranasal insulin intensifies satiety and reduces intake of palatable snacks in women Diabetes 2012, 61, 782-789
54. Kullmann, S.; Frank, S.; Heni, M.; Ketterer, C.; Veit, R.; Haring, H. U.; Fritsche, A.; Preissl, H. Intranasal insulin modulates intrinsic reward and prefrontal circuitry of the human brain in lean women Neuroendocrinology 2013, 97, 176-182
55. Clegg, D. J.; Riedy, C. A.; Smith, K. A.; Benoit, S. C.; Woods, S. C. Differential sensitivity to central leptin and insulin in male and female rats Diabetes 2003, 52, 682-687
56. Clegg, D. J.; Brown, L. M.; Woods, S. C.; Benoit, S. C. Gonadal hormones determine sensitivity to central leptin and insulin Diabetes 2006, 55, 978-987
57. Rahmouni, K.; Morgan, D. A.; Morgan, G. M.; Liu, X.; Sigmund, C. D.; Mark, A. L.; Haynes, W. G. Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin J. Clin. Invest. 2004, 114, 652-658
58. Sanchez-Alavez, M.; Tabarean, I. V.; Osborn, O.; Mitsukawa, K.; Schaefer, J.; Dubins, J.; Holmberg, K. H.; Klein, I.; Klaus, J.; Gomez, L. F.; Kolb, H.; Secrest, J.; Jochems, J.; Myashiro, K.; Buckley, P.; Hadcock, J. R.; Eberwine, J.; Conti, B.; Bartfai, T. Insulin causes hyperthermia by direct inhibition of warm-sensitive neurons Diabetes 2010, 59, 43-50
59. Koch, L.; Wunderlich, F. T.; Seibler, J.; Konner, A. C.; Hampel, B.; Irlenbusch, S.; Brabant, G.; Kahn, C. R.; Schwenk, F.; Bruning, J. C. Central insulin action regulates peripheral glucose and fat metabolism in mice J. Clin. Invest. 2008, 118, 2132-2147
60. Scherer, T.; O'Hare, J.; Diggs-Andrews, K.; Schweiger, M.; Cheng, B.; Lindtner, C.; Zielinski, E.; Vempati, P.; Su, K.; Dighe, S.; Milsom, T.; Puchowicz, M.; Scheja, L.; Zechner, R.; Fisher, S. J.; Previs, S. F.; Buettner, C. Brain insulin controls adipose tissue lipolysis and lipogenesis Cell Metab. 2011, 13, 183-194
61. Iwen, K. A.; Scherer, T.; Heni, M.; Sayk, F.; Wellnitz, T.; Machleidt, F.; Preissl, H.; Haring, H. U.; Fritsche, A.; Lehnert, H.; Buettner, C.; Hallschmid, M. Intranasal insulin suppresses systemic but not subcutaneous lipolysis in healthy humans J. Clin. Endocrinol. Metab. 2014, 99, E246-E251
62. Cherrington, A. D. The role of hepatic insulin receptors in the regulation of glucose production J. Clin. Invest. 2005, 115, 1136-1139
63. Obici, S.; Feng, Z.; Karkanias, G.; Baskin, D. G.; Rossetti, L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats Nat. Neurosci. 2002, 5, 566-572
64. Edgerton, D. S.; Lautz, M.; Scott, M.; Everett, C. A.; Stettler, K. M.; Neal, D. W.; Chu, C. A.; Cherrington, A. D. Insulin's direct effects on the liver dominate the control of hepatic glucose production J. Clin. Invest. 2006, 116, 521-527
65. Ramnanan, C. J.; Saraswathi, V.; Smith, M. S.; Donahue, E. P.; Farmer, B.; Farmer, T. D.; Neal, D.; Williams, P. E.; Lautz, M.; Mari, A.; Cherrington, A. D.; Edgerton, D. S. Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs J. Clin. Invest. 2011, 121, 3713-3723
66. Woods, S. C.; Porte, D., Jr. Effect of intracisternal insulin on plasma glucose and insulin in the dog Diabetes 1975, 24, 905-909
67. Bouche, C.; Lopez, X.; Fleischman, A.; Cypess, A. M.; O'Shea, S.; Stefanovski, D.; Bergman, R. N.; Rogatsky, E.; Stein, D. T.; Kahn, C. R.; Kulkarni, R. N.; Goldfine, A. B. Insulin enhances glucose-stimulated insulin secretion in healthy humans Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 4770-4775
68. Kishore, P.; Boucai, L.; Zhang, K.; Li, W.; Koppaka, S.; Kehlenbrink, S.; Schiwek, A.; Esterson, Y. B.; Mehta, D.; Bursheh, S.; Su, Y.; Gutierrez-Juarez, R.; Muzumdar, R.; Schwartz, G. J.; Hawkins, M. Activation of K(ATP) channels suppresses glucose production in humans J. Clin. Invest. 2011, 121, 4916-4920
69. Heni, M.; Wagner, R.; Kullmann, S.; Veit, R.; Mat, H. H.; Linder, K.; Benkendorff, C.; Peter, A.; Stefan, N.; Haring, H. U.; Preissl, H.; Fritsche, A. Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men Diabetes 2014, 63, 4083-4088
70. Stockhorst, U.; de Fries, D.; Steingrueber, H. J.; Scherbaum, W. A. Unconditioned and conditioned effects of intranasally administered insulin vs placebo in healthy men: a randomised controlled trial Diabetologia 2011, 54, 1502-1506
71. Ramnanan, C. J.; Edgerton, D. S.; Cherrington, A. D. Evidence against a physiologic role for acute changes in CNS insulin action in the rapid regulation of hepatic glucose production Cell Metab. 2012, 15, 656-664
72. Ramnanan, C. J.; Kraft, G.; Smith, M. S.; Farmer, B.; Neal, D.; Williams, P. E.; Lautz, M.; Farmer, T.; Donahue, E. P.; Cherrington, A. D.; Edgerton, D. S. Interaction between the central and peripheral effects of insulin in controlling hepatic glucose metabolism in the conscious dog Diabetes 2013, 62, 74-84
73. Perseghin, G.; Regalia, E.; Battezzati, A.; Vergani, S.; Pulvirenti, A.; Terruzzi, I.; Baratti, D.; Bozzetti, F.; Mazzaferro, V.; Luzi, L. Regulation of glucose homeostasis in humans with denervated livers J. Clin. Invest. 1997, 100, 931-941
74. Edgerton, D. S.; Cherrington, A. D. Is brain insulin action relevant to the control of plasma glucose in humans? Diabetes 2015, 64, 696-699
75. Sainz, N.; Barrenetxe, J.; Moreno-Aliaga, M. J.; Martinez, J. A. Leptin resistance and diet-induced obesity: central and peripheral actions of leptin Metabolism 2015, 64, 35-46
76. Guo, K.; McMinn, J. E.; Ludwig, T.; Yu, Y. H.; Yang, G.; Chen, L.; Loh, D.; Li, C.; Chua, S., Jr.; Zhang, Y. Disruption of peripheral leptin signaling in mice results in hyperleptinemia without associated metabolic abnormalities Endocrinology 2007, 148, 3987-3997
77. de Luca, C.; Kowalski, T. J.; Zhang, Y.; Elmquist, J. K.; Lee, C.; Kilimann, M. W.; Ludwig, T.; Liu, S. M.; Chua, S. C., Jr. Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes J. Clin. Invest. 2005, 115, 3484-3493
78. Jastreboff, A. M.; Lacadie, C.; Seo, D.; Kubat, J.; Van Name, M. A.; Giannini, C.; Savoye, M.; Constable, R. T.; Sherwin, R. S.; Caprio, S.; Sinha, R. Leptin is associated with exaggerated brain reward and emotion responses to food images in adolescent obesity Diabetes Care 2014, 37, 3061-3068
79. Baicy, K.; London, E. D.; Monterosso, J.; Wong, M. L.; Delibasi, T.; Sharma, A.; Licinio, J. Leptin replacement alters brain response to food cues in genetically leptin-deficient adults Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 18276-18279
80. Farooqi, I. S.; Bullmore, E.; Keogh, J.; Gillard, J.; O'Rahilly, S.; Fletcher, P. C. Leptin regulates striatal regions and human eating behavior Science 2007, 317, 1355
81. Farr, O. M.; Fiorenza, C.; Papageorgiou, P.; Brinkoetter, M.; Ziemke, F.; Koo, B. B.; Rojas, R.; Mantzoros, C. S. Leptin therapy alters appetite and neural responses to food stimuli in brain areas of leptin-sensitive subjects without altering brain structure J. Clin. Endocrinol. Metab. 2014, 99, E2529-E2538
82. Schulz, C.; Paulus, K.; Lehnert, H. Central nervous and metabolic effects of intranasally applied leptin Endocrinology 2004, 145, 2696-2701
83. Blevins, J. E.; Schwartz, M. W.; Baskin, D. G. Evidence that paraventricular nucleus oxytocin neurons link hypothalamic leptin action to caudal brain stem nuclei controlling meal size Am. J. Physiol. 2004, 287, R87-R96
84. Olson, B. R.; Drutarosky, M. D.; Chow, M. S.; Hruby, V. J.; Stricker, E. M.; Verbalis, J. G. Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats Peptides 1991, 12, 113-118
85. Noble, E. E.; Billington, C. J.; Kotz, C. M.; Wang, C. Oxytocin in the ventromedial hypothalamic nucleus reduces feeding and acutely increases energy expenditure Am. J. Physiol. 2014, 307, R737-R745
86. Camerino, C. Low sympathetic tone and obese phenotype in oxytocin-deficient mice Obesity 2009, 17, 980-984
87. Takayanagi, Y.; Kasahara, Y.; Onaka, T.; Takahashi, N.; Kawada, T.; Nishimori, K. Oxytocin receptor-deficient mice developed late-onset obesity NeuroReport 2008, 19, 951-955
88. Blevins, J. E.; Ho, J. M. Role of oxytocin signaling in the regulation of body weight Rev. Endocr. Metab. Disord. 2013, 14, 311-329
89. Melis, M. R.; Succu, S.; Sanna, F.; Boi, A.; Argiolas, A. Oxytocin injected into the ventral subiculum or the posteromedial cortical nucleus of the amygdala induces penile erection and increases extracellular dopamine levels in the nucleus accumbens of male rats Eur. J. Neurosci. 2009, 30, 1349-1357
90. Qi, J.; Yang, J. Y.; Song, M.; Li, Y.; Wang, F.; Wu, C. F. Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice Naunyn-Schmiedeberg's Arch. Pharmacol. 2008, 376, 441-448
91. Atasoy, D.; Betley, J. N.; Su, H. H.; Sternson, S. M. Deconstruction of a neural circuit for hunger Nature 2012, 488, 172-177
92. Heinrichs, M.; Baumgartner, T.; Kirschbaum, C.; Ehlert, U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress Biol. Psychiatry 2003, 54, 1389-1398
93. Deblon, N.; Veyrat-Durebex, C.; Bourgoin, L.; Caillon, A.; Bussier, A. L.; Petrosino, S.; Piscitelli, F.; Legros, J. J.; Geenen, V.; Foti, M.; Wahli, W.; Di Marzo, V.; Rohner-Jeanrenaud, F. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats PLoS One 2011, 6, e25565
94. Scheele, D.; Wille, A.; Kendrick, K. M.; Stoffel-Wagner, B.; Becker, B.; Gunturkun, O.; Maier, W.; Hurlemann, R. Oxytocin enhances brain reward system responses in men viewing the face of their female partner Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 20308-20313
95. Dolen, G.; Darvishzadeh, A.; Huang, K. W.; Malenka, R. C. Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin Nature 2013, 501, 179-184
96. Swaab, D. F.; Purba, J. S.; Hofman, M. A. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases J. Clin. Endocrinol. Metab. 1995, 80, 573-579
97. Einfeld, S. L.; Smith, E.; McGregor, I. S.; Steinbeck, K.; Taffe, J.; Rice, L. J.; Horstead, S. K.; Rogers, N.; Hodge, M. A.; Guastella, A. J. A double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome Am. J. Med. Genet., Part A 2014, 164A, 2232-2239
98. Diekelmann, S.; Born, J. The memory function of sleep Nat. Rev. Neurosci. 2010, 11, 114-126
99. Moult, P. R.; Harvey, J. Hormonal regulation of hippocampal dendritic morphology and synaptic plasticity Cell Adhes. Migr. 2008, 2, 269-275
100. Chiu, S. L.; Chen, C. M.; Cline, H. T. Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo Neuron 2008, 58, 708-719
101. Doyle, P.; Cusin, I.; Rohner-Jeanrenaud, F.; Jeanrenaud, B. Four-day hyperinsulinemia in euglycemic conditions alters local cerebral glucose utilization in specific brain nuclei of freely moving rats Brain Res. 1995, 684, 47-55
102. Benedict, C.; Hallschmid, M.; Schmitz, K.; Schultes, B.; Ratter, F.; Fehm, H. L.; Born, J.; Kern, W. Intranasal insulin improves memory in humans: superiority of insulin aspart Neuropsychopharmacology 2007, 32, 239-243
103. Benedict, C.; Hallschmid, M.; Hatke, A.; Schultes, B.; Fehm, H. L.; Born, J.; Kern, W. Intranasal insulin improves memory in humans Psychoneuroendocrinology 2004, 29, 1326-1334
104. Brunner, Y. F.; Benedict, C.; Freiherr, J. Intranasal insulin reduces olfactory sensitivity in normosmic humans J. Clin. Endocrinol. Metab. 2013, 98, E1626-E1630
105. Brunner, Y. F.; Kofoet, A.; Benedict, C.; Freiherr, J. Central insulin administration improves odor-cued reactivation of spatial memory in young men J. Clin. Endocrinol. Metab. 2015, 100, 212-219
106. Grillo, C. A.; Piroli, G. G.; Kaigler, K. F.; Wilson, S. P.; Wilson, M. A.; Reagan, L. P. Downregulation of hypothalamic insulin receptor expression elicits depressive-like behaviors in rats Behav. Brain Res. 2011, 222, 230-235
107. Marks, D. R.; Tucker, K.; Cavallin, M. A.; Mast, T. G.; Fadool, D. A. Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors J. Neurosci. 2009, 29, 6734-6751
108. Moult, P. R.; Cross, A.; Santos, S. D.; Carvalho, A. L.; Lindsay, Y.; Connolly, C. N.; Irving, A. J.; Leslie, N. R.; Harvey, J. Leptin regulates AMPA receptor trafficking via PTEN inhibition J. Neurosci. 2010, 30, 4088-4101
109. Shanley, L. J.; Irving, A. J.; Harvey, J. Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity J. Neurosci. 2001, 21, RC186
110. Xu, L.; Rensing, N.; Yang, X. F.; Zhang, H. X.; Thio, L. L.; Rothman, S. M.; Weisenfeld, A. E.; Wong, M.; Yamada, K. A. Leptin inhibits 4-aminopyridine- and pentylenetetrazole-induced seizures and AMPAR-mediated synaptic transmission in rodents J. Clin. Invest. 2008, 118, 272-280
111. Farr, S. A.; Banks, W. A.; Morley, J. E. Effects of leptin on memory processing Peptides 2006, 27, 1420-1425
112. Kanoski, S. E.; Hayes, M. R.; Greenwald, H. S.; Fortin, S. M.; Gianessi, C. A.; Gilbert, J. R.; Grill, H. J. Hippocampal leptin signaling reduces food intake and modulates food-related memory processing Neuropsychopharmacology 2011, 36, 1859-1870
113. Irving, A. J.; Harvey, J. Leptin regulation of hippocampal synaptic function in health and disease Philos. Trans. R. Soc. London, Ser. B 2014, 369, 20130155
114. Lu, X. Y.; Kim, C. S.; Frazer, A.; Zhang, W. Leptin: a potential novel antidepressant Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 1593-1598
115. Farr, O. M.; Tsoukas, M. A.; Mantzoros, C. S. Leptin and the brain: Influences on brain development, cognitive functioning and psychiatric disorders Metabolism 2015, 64, 114-130
116. Feldman, R.; Weller, A.; Zagoory-Sharon, O.; Levine, A. Evidence for a neuroendocrinological foundation of human affiliation: plasma oxytocin levels across pregnancy and the postpartum period predict mother-infant bonding Psychol. Sci. 2007, 18, 965-970
117. Chen, F. S.; Mayer, J.; Mussweiler, T.; Heinrichs, M. Oxytocin increases the likeability of physically formidable men Soc. Cognit. Affective Neurosci. 2014, 10.1093/scan/nsu116
118. Bartz, J. A.; Zaki, J.; Bolger, N.; Hollander, E.; Ludwig, N. N.; Kolevzon, A.; Ochsner, K. N. Oxytocin selectively improves empathic accuracy Psychol. Sci. 2010, 21, 1426-1428
119. Shahrestani, S.; Kemp, A. H.; Guastella, A. J. The impact of a single administration of intranasal oxytocin on the recognition of basic emotions in humans: a meta-analysis Neuropsychopharmacology 2013, 38, 1929-1936
120. Rimmele, U.; Hediger, K.; Heinrichs, M.; Klaver, P. Oxytocin makes a face in memory familiar J. Neurosci. 2009, 29, 38-42
121. Kosfeld, M.; Heinrichs, M.; Zak, P. J.; Fischbacher, U.; Fehr, E. Oxytocin increases trust in humans Nature 2005, 435, 673-676
122. Nakajima, M.; Gorlich, A.; Heintz, N. Oxytocin modulates female sociosexual behavior through a specific class of prefrontal cortical interneurons Cell 2014, 159, 295-305
123. Behnia, B.; Heinrichs, M.; Bergmann, W.; Jung, S.; Germann, J.; Schedlowski, M.; Hartmann, U.; Kruger, T. H. Differential effects of intranasal oxytocin on sexual experiences and partner interactions in couples Horm. Behav. 2014, 65, 308-318
124. Bakermans-Kranenburg, M. J.; van IJzendoorn, M. H. Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy Transl. Psychiatry 2013, 3, e258
125. Higgs, S. Cognitive influences on food intake: the effects of manipulating memory for recent eating Physiol. Behav. 2008, 94, 734-739
126. Higgs, S.; Williamson, A. C.; Attwood, A. S. Recall of recent lunch and its effect on subsequent snack intake Physiol. Behav. 2008, 94, 454-462
127. Rozin, P.; Dow, S.; Moscovitch, M.; Rajaram, S. What causes humans to begin and end a meal? A role for memory for what has been eaten, as evidenced by a study of multiple meal eating in amnesic patients Psychol. Sci. 1998, 9, 392-396
128. Shin, A. C.; Zheng, H.; Berthoud, H. R. An expanded view of energy homeostasis: neural integration of metabolic, cognitive, and emotional drives to eat Physiol. Behav. 2009, 97, 572-580
129. Tschritter, O.; Preissl, H.; Hennige, A. M.; Sartorius, T.; Stingl, K. T.; Heni, M.; Ketterer, C.; Stefan, N.; Machann, J.; Schleicher, E.; Fritsche, A.; Haring, H. U. High cerebral insulin sensitivity is associated with loss of body fat during lifestyle intervention Diabetologia 2012, 55, 175-182
130. Guthoff, M.; Stingl, K. T.; Tschritter, O.; Rogic, M.; Heni, M.; Stingl, K.; Hallschmid, M.; Haring, H. U.; Fritsche, A.; Preissl, H.; Hennige, A. M. The insulin-mediated modulation of visually evoked magnetic fields is reduced in obese subjects PLoS One 2011, 6, e19482
131. Kullmann, S.; Heni, M.; Veit, R.; Scheffler, K.; Machann, J.; Haring, H. U.; Fritsche, A.; Preissl, H. Selective insulin resistance in homeostatic and cognitive control brain areas in overweight and obese adults Diabetes Care 2015, 10.2337/dc14-2319
132. Hallschmid, M.; Benedict, C.; Schultes, B.; Born, J.; Kern, W. Obese men respond to cognitive but not to catabolic brain insulin signaling Int. J. Obes. (London) 2008, 32, 275-282
133. Ono, H.; Pocai, A.; Wang, Y.; Sakoda, H.; Asano, T.; Backer, J. M.; Schwartz, G. J.; Rossetti, L. Activation of hypothalamic S6 kinase mediates diet-induced hepatic insulin resistance in rats J. Clin. Invest. 2008, 118, 2959-2968
134. Scherer, T.; Lindtner, C.; Zielinski, E.; O'Hare, J.; Filatova, N.; Buettner, C. Short term voluntary overfeeding disrupts brain insulin control of adipose tissue lipolysis J. Biol. Chem. 2012, 287, 33061-33069
135. Kern, W.; Benedict, C.; Schultes, B.; Plohr, F.; Moser, A.; Born, J.; Fehm, H. L.; Hallschmid, M. Low cerebrospinal fluid insulin levels in obese humans Diabetologia 2006, 49, 2790-2792
136. Schwartz, M. W.; Porte, D., Jr. Diabetes, obesity, and the brain Science 2005, 307, 375-379
137. Begg, D. P.; Mul, J. D.; Liu, M.; Reedy, B. M.; D'Alessio, D. A.; Seeley, R. J.; Woods, S. C. Reversal of diet-induced obesity increases insulin transport into cerebrospinal fluid and restores sensitivity to the anorexic action of central insulin in male rats Endocrinology 2013, 154, 1047-1054
138. Heymsfield, S. B.; Greenberg, A. S.; Fujioka, K.; Dixon, R. M.; Kushner, R.; Hunt, T.; Lubina, J. A.; Patane, J.; Self, B.; Hunt, P.; McCamish, M. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial JAMA, J. Am. Med. Assoc. 1999, 282, 1568-1575
139. El-Haschimi, K.; Pierroz, D. D.; Hileman, S. M.; Bjorbaek, C.; Flier, J. S. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity J. Clin. Invest. 2000, 105, 1827-1832
140. Burguera, B.; Couce, M. E.; Curran, G. L.; Jensen, M. D.; Lloyd, R. V.; Cleary, M. P.; Poduslo, J. F. Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats Diabetes 2000, 49, 1219-1223
141. Caro, J. F.; Kolaczynski, J. W.; Nyce, M. R.; Ohannesian, J. P.; Opentanova, I.; Goldman, W. H.; Lynn, R. B.; Zhang, P. L.; Sinha, M. K.; Considine, R. V. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance Lancet 1996, 348, 159-161
142. Moon, H. S.; Matarese, G.; Brennan, A. M.; Chamberland, J. P.; Liu, X.; Fiorenza, C. G.; Mylvaganam, G. H.; Abanni, L.; Carbone, F.; Williams, C. J.; De Paoli, A. M.; Schneider, B. E.; Mantzoros, C. S. Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance Diabetes 2011, 60, 1647-1656
143. Kerti, L.; Witte, A. V.; Winkler, A.; Grittner, U.; Rujescu, D.; Floel, A. Higher glucose levels associated with lower memory and reduced hippocampal microstructure Neurology 2013, 81, 1746-1752
144. McCrimmon, R. J.; Ryan, C. M.; Frier, B. M. Diabetes and cognitive dysfunction Lancet 2012, 379, 2291-2299
145. Whitmer, R. A.; Gunderson, E. P.; Barrett-Connor, E.; Quesenberry, C. P., Jr.; Yaffe, K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study BMJ 2005, 330, 1360
146. Trudeau, F.; Gagnon, S.; Massicotte, G. Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus Eur. J. Pharmacol. 2004, 490, 177-186
147. De Felice, F. G.; Vieira, M. N.; Bomfim, T. R.; Decker, H.; Velasco, P. T.; Lambert, M. P.; Viola, K. L.; Zhao, W. Q.; Ferreira, S. T.; Klein, W. L. Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 1971-1976
148. Chen, Y.; Zhao, Y.; Dai, C. L.; Liang, Z.; Run, X.; Iqbal, K.; Liu, F.; Gong, C. X. Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Abeta level and microglia activation in the brains of 3xTg-AD mice Exp. Neurol. 2014, 261, 610-619
149. De Felice, F. G. Alzheimer's disease and insulin resistance: translating basic science into clinical applications J. Clin. Invest. 2013, 123, 531-539
150. Craft, S.; Peskind, E.; Schwartz, M. W.; Schellenberg, G. D.; Raskind, M.; Porte, D., Jr. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype Neurology 1998, 50, 164-168
151. Talbot, K.; Wang, H. Y.; Kazi, H.; Han, L. Y.; Bakshi, K. P.; Stucky, A.; Fuino, R. L.; Kawaguchi, K. R.; Samoyedny, A. J.; Wilson, R. S.; Arvanitakis, Z.; Schneider, J. A.; Wolf, B. A.; Bennett, D. A.; Trojanowski, J. Q.; Arnold, S. E. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline J. Clin. Invest. 2012, 122, 1316-1338
152. Reger, M. A.; Watson, G. S.; Green, P. S.; Baker, L. D.; Cholerton, B.; Fishel, M. A.; Plymate, S. R.; Cherrier, M. M.; Schellenberg, G. D.; Frey, W. H.; Craft, S. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults J. Alzheimer's Dis. 2008, 13, 323-331
153. Reger, M. A.; Watson, G. S.; Frey, W. H.; Baker, L. D.; Cholerton, B.; Keeling, M. L.; Belongia, D. A.; Fishel, M. A.; Plymate, S. R.; Schellenberg, G. D.; Cherrier, M. M.; Craft, S. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype Neurobiol. Aging 2006, 27, 451-458
154. Ketterer, C.; Heni, M.; Stingl, K.; Tschritter, O.; Linder, K.; Wagner, R.; Machicao, F.; Haring, H. U.; Preissl, H.; Staiger, H.; Fritsche, A. Polymorphism rs3123554 in CNR2 reveals gender-specific effects on body weight and affects loss of body weight and cerebral insulin action Obesity 2014, 22, 925-931
155. Beccano-Kelly, D.; Harvey, J. Leptin: a novel therapeutic target in Alzheimer's disease? Int. J. Alzheimer's Dis. 2012, 2012, 594137
156. Li, X. L.; Aou, S.; Oomura, Y.; Hori, N.; Fukunaga, K.; Hori, T. Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents Neuroscience 2002, 113, 607-615
157. Wayner, M. J.; Armstrong, D. L.; Phelix, C. F.; Oomura, Y. Orexin-A (Hypocretin-1) and leptin enhance LTP in the dentate gyrus of rats in vivo Peptides 2004, 25, 991-996
158. Novak, V.; Milberg, W.; Hao, Y.; Munshi, M.; Novak, P.; Galica, A.; Manor, B.; Roberson, P.; Craft, S.; Abduljalil, A. Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes Diabetes Care 2014, 37, 751-759
159. Shemesh, E.; Rudich, A.; Harman-Boehm, I.; Cukierman-Yaffe, T. Effect of intranasal insulin on cognitive function: a systematic review J. Clin. Endocrinol. Metab. 2012, 97, 366-376
160. MacDonald, E.; Dadds, M. R.; Brennan, J. L.; Williams, K.; Levy, F.; Cauchi, A. J. A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research Psychoneuroendocrinology 2011, 36, 1114-1126
161. Zhang, H.; Hao, Y.; Manor, B.; Novak, P.; Milberg, W.; Zhang, J.; Fang, J.; Novak, V. Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes Diabetes 2015, 64, 1025-1034
162. Reger, M. A.; Watson, G. S.; Green, P. S.; Wilkinson, C. W.; Baker, L. D.; Cholerton, B.; Fishel, M. A.; Plymate, S. R.; Breitner, J. C.; DeGroodt, W.; Mehta, P.; Craft, S. Intranasal insulin improves cognition and modulates beta-amyloid in early AD Neurology 2008, 70, 440-448
163. Craft, S.; Baker, L. D.; Montine, T. J.; Minoshima, S.; Watson, G. S.; Claxton, A.; Arbuckle, M.; Callaghan, M.; Tsai, E.; Plymate, S. R.; Green, P. S.; Leverenz, J.; Cross, D.; Gerton, B. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial Arch. Neurol. 2012, 69, 29-38
164. Mosconi, L.; Pupi, A.; de Leon, M. J. Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease Ann. N.Y. Acad. Sci. 2008, 1147, 180-195
165. Schmidt, H.; Kern, W.; Giese, R.; Hallschmid, M.; Enders, A. Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial J. Med. Genet. 2009, 46, 217-222
166. Freiherr, J.; Hallschmid, M.; Frey, W. H.; Brunner, Y. F.; Chapman, C. D.; Holscher, C.; Craft, S.; De Felice, F. G.; Benedict, C. Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence CNS Drugs 2013, 27, 505-514
167. Gupta, A.; Bisht, B.; Dey, C. S. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes Neuropharmacology 2011, 60, 910-920
168. Landreth, G.; Jiang, Q.; Mandrekar, S.; Heneka, M. PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease Neurotherapeutics 2008, 5, 481-489
169. Pathan, A. R.; Gaikwad, A. B.; Viswanad, B.; Ramarao, P. Rosiglitazone attenuates the cognitive deficits induced by high fat diet feeding in rats Eur. J. Pharmacol. 2008, 589, 176-179
170. Risner, M. E.; Saunders, A. M.; Altman, J. F.; Ormandy, G. C.; Craft, S.; Foley, I. M.; Zvartau-Hind, M. E.; Hosford, D. A.; Roses, A. D. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease Pharmacogenomics J. 2006, 6, 246-254
171. Miller, B. W.; Willett, K. C.; Desilets, A. R. Rosiglitazone and pioglitazone for the treatment of Alzheimer's disease Ann. Pharmacother. 2011, 45, 1416-1424
172. Patrone, C.; Eriksson, O.; Lindholm, D. Diabetes drugs and neurological disorders: new views and therapeutic possibilities Lancet Diabetes Endocrinol. 2014, 2, 256-262
173. Yarchoan, M.; Arnold, S. E. Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease Diabetes 2014, 63, 2253-2261
174. Bohringer, A.; Schwabe, L.; Richter, S.; Schachinger, H. Intranasal insulin attenuates the hypothalamic-pituitary-adrenal axis response to psychosocial stress Psychoneuroendocrinology 2008, 33, 1394-1400
175. Doherty, G. H.; Beccano-Kelly, D.; Yan, S. D.; Gunn-Moore, F. J.; Harvey, J. Leptin prevents hippocampal synaptic disruption and neuronal cell death induced by amyloid beta Neurobiol. Aging 2013, 34, 226-237
176. Sumithran, P.; Prendergast, L. A.; Delbridge, E.; Purcell, K.; Shulkes, A.; Kriketos, A.; Proietto, J. Long-term persistence of hormonal adaptations to weight loss N. Engl. J. Med. 2011, 365, 1597-1604
177. Rosenbaum, M.; Goldsmith, R.; Bloomfield, D.; Magnano, A.; Weimer, L.; Heymsfield, S.; Gallagher, D.; Mayer, L.; Murphy, E.; Leibel, R. L. Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight J. Clin. Invest. 2005, 115, 3579-3586
178. Rosenbaum, M.; Sy, M.; Pavlovich, K.; Leibel, R. L.; Hirsch, J. Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli J. Clin. Invest. 2008, 118, 2583-2591
179. Schulz, C.; Paulus, K.; Johren, O.; Lehnert, H. Intranasal leptin reduces appetite and induces weight loss in rats with diet-induced obesity (DIO) Endocrinology 2012, 153, 143-153
180. Iwasaki, Y.; Maejima, Y.; Suyama, S.; Yoshida, M.; Arai, T.; Katsurada, K.; Kumari, P.; Nakabayashi, H.; Kakei, M.; Yada, T. Peripheral oxytocin activates vagal afferent neurons to suppress feeding in normal and leptin-resistant mice: A route for ameliorating hyperphagia and obesity Am. J. Physiol. 2015, 308, R360-369
181. Altirriba, J.; Poher, A. L.; Caillon, A.; Arsenijevic, D.; Veyrat-Durebex, C.; Lyautey, J.; Dulloo, A.; Rohner-Jeanrenaud, F. Divergent effects of oxytocin treatment of obese diabetic mice on adiposity and diabetes Endocrinology 2014, 155, 4189-4201
182. Maejima, Y.; Iwasaki, Y.; Yamahara, Y.; Kodaira, M.; Sedbazar, U.; Yada, T. Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass Aging 2011, 3, 1169-1177
183. Zhang, G.; Bai, H.; Zhang, H.; Dean, C.; Wu, Q.; Li, J.; Guariglia, S.; Meng, Q.; Cai, D. Neuropeptide exocytosis involving synaptotagmin-4 and oxytocin in hypothalamic programming of body weight and energy balance Neuron 2011, 69, 523-535
184. Blevins, J. E.; Graham, J. L.; Morton, G. J.; Bales, K. L.; Schwartz, M. W.; Baskin, D. G.; Havel, P. J. Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys Am. J. Physiol. 2015, 308, R431-438
185. Kim, Y. R.; Kim, C. H.; Cardi, V.; Eom, J. S.; Seong, Y.; Treasure, J. Intranasal oxytocin attenuates attentional bias for eating and fat shape stimuli in patients with anorexia nervosa Psychoneuroendocrinology 2014, 44, 133-142
186. Kamei, N.; Takeda-Morishita, M. Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides J. Controlled Release 2015, 197, 105-110
187. Fishel, M. A.; Watson, G. S.; Montine, T. J.; Wang, Q.; Green, P. S.; Kulstad, J. J.; Cook, D. G.; Peskind, E. R.; Baker, L. D.; Goldgaber, D.; Nie, W.; Asthana, S.; Plymate, S. R.; Schwartz, M. W.; Craft, S. Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults Arch. Neurol. 2005, 62, 1539-1544
188. Mayer, C. M.; Belsham, D. D. Central insulin signaling is attenuated by long-term insulin exposure via insulin receptor substrate-1 serine phosphorylation, proteasomal degradation, and lysosomal insulin receptor degradation Endocrinology 2010, 151, 75-84
189. Claxton, A.; Baker, L. D.; Hanson, A.; Trittschuh, E. H.; Cholerton, B.; Morgan, A.; Callaghan, M.; Arbuckle, M.; Behl, C.; Craft, S. Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia J. Alzheimer's Dis. 2015, 44 (3) 897-906 10.3233/JAD-141791
190. Qian, W.; Zhu, T.; Tang, B.; Yu, S.; Hu, H.; Sun, W.; Pan, R.; Wang, J.; Wang, D.; Yang, L.; Mao, C.; Zhou, L.; Yuan, G. Decreased circulating levels of oxytocin in obesity and newly diagnosed type 2 diabetic patients J. Clin. Endocrinol. Metab. 2014, 99, 4683-4689
191. Stock, S.; Granstrom, L.; Backman, L.; Matthiesen, A. S.; Uvnas-Moberg, K. Elevated plasma levels of oxytocin in obese subjects before and after gastric banding Int. J. Obes. 1989, 13, 213-222
192. De Dreu, C. K.; Greer, L. L.; Van Kleef, G. A.; Shalvi, S.; Handgraaf, M. J. Oxytocin promotes human ethnocentrism Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 1262-1266
193. Shalvi, S.; De Dreu, C. K. Oxytocin promotes group-serving dishonesty Proc. Natl. Acad. Sci. U.S.A. 2014, 111, 5503-5507
194. Shamay-Tsoory, S. G.; Fischer, M.; Dvash, J.; Harari, H.; Perach-Bloom, N.; Levkovitz, Y. Intranasal administration of oxytocin increases envy and schadenfreude (gloating) Biol. Psychiatry 2009, 66, 864-870
195. Huang, H.; Michetti, C.; Busnelli, M.; Manago, F.; Sannino, S.; Scheggia, D.; Giancardo, L.; Sona, D.; Murino, V.; Chini, B.; Scattoni, M. L.; Papaleo, F. Chronic and acute intranasal oxytocin produce divergent social effects in mice Neuropsychopharmacology 2014, 39, 1102-1114